Citation 32922

ROBAK,J: SHRIDI,F: WOLBIS,M: KROLIKOWSKA,M:. (1988). SCREENING OF THE INFLUENCE OF FLAVONOIDS ON LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITY, AS WELL AS ON NONENZYMIC LIPID OXIDATION.. 40(5)

Citation Details

TitleSCREENING OF THE INFLUENCE OF FLAVONOIDS ON LIPOXYGENASE AND CYCLOOXYGENASE ACTIVITY, AS WELL AS ON NONENZYMIC LIPID OXIDATION.
AuthorsROBAK,J: SHRIDI,F: WOLBIS,M: KROLIKOWSKA,M:
Year1988
Volume40
Issue5

Summary

Year: 1988

Journal: Unknown

Organisms and Their Experiments (23)

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 7-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-RHAMNOSIDEKAEMPFEROL-3-GLUCOSIDE-7-RHAMNOSIDEKAEMPFERITRINRHAMNETIN,ISO: 3-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-O-RUTINOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 7-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-RHAMNOSIDEKAEMPFEROL-3-GLUCOSIDE-7-RHAMNOSIDEKAEMPFERITRINRHAMNETIN,ISO: 3-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-O-RUTINOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 7-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-RHAMNOSIDEKAEMPFEROL-3-GLUCOSIDE-7-RHAMNOSIDEKAEMPFERITRINRHAMNETIN,ISO: 3-O-BETA-D-GLUCOSIDERHAMNETIN,ISO: 3-O-RUTINOSIDE
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICITRINQUERCITRIN,ISO:MYRICETIN-3-O-BETA-D-GLUCOSIDEFOENICULIN
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICITRINQUERCITRIN,ISO:MYRICETIN-3-O-BETA-D-GLUCOSIDEFOENICULIN
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICITRINQUERCITRIN,ISO:MYRICETIN-3-O-BETA-D-GLUCOSIDEFOENICULIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY:LUTEOLINMYRICETIN
STRONG ACTIVITY
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY:LUTEOLINMYRICETIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY:LUTEOLINMYRICETIN
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CYNAROSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CYNAROSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
CYNAROSIDE
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY: 7-O-BETA-D-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY: 7-O-BETA-D-GLUCOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LUTEOLIN,6-HYDROXY: 7-O-BETA-D-GLUCOSIDE
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN
ACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN-7-O-BETA-D-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN-7-O-BETA-D-GLUCOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
NEPETIN-7-O-BETA-D-GLUCOSIDE
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL
ACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-7-RHAMNOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-7-RHAMNOSIDE
WEAK ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-7-RHAMNOSIDE
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-3-RHAMNOSIDERHAMNETIN,ISO: 3-GLUCOSIDE-7-RHAMNOSIDERHAMNETIN,ISO: 3-7-DI-GLUCOSIDERHAMNETIN,ISO: 3-SOPHOROSIDE-7-RHAMNOSIDELIMOCITRIN-3-7-DIGLUCOSIDELIMOCITRIN-3-O-BETA-D-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-3-RHAMNOSIDERHAMNETIN,ISO: 3-GLUCOSIDE-7-RHAMNOSIDERHAMNETIN,ISO: 3-7-DI-GLUCOSIDERHAMNETIN,ISO: 3-SOPHOROSIDE-7-RHAMNOSIDELIMOCITRIN-3-7-DIGLUCOSIDELIMOCITRIN-3-O-BETA-D-GLUCOSIDE
WEAK ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
KAEMPFEROL-3-RHAMNOSIDERHAMNETIN,ISO: 3-GLUCOSIDE-7-RHAMNOSIDERHAMNETIN,ISO: 3-7-DI-GLUCOSIDERHAMNETIN,ISO: 3-SOPHOROSIDE-7-RHAMNOSIDELIMOCITRIN-3-7-DIGLUCOSIDELIMOCITRIN-3-O-BETA-D-GLUCOSIDE
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETINQUERCETAGETIN
STRONG ACTIVITY
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETINQUERCETAGETIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETINQUERCETAGETIN
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCIMERITRIN
ACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCIMERITRIN
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCIMERITRIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETIN-3-GLUCOSIDE-7-RHAMNOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETIN-3-GLUCOSIDE-7-RHAMNOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETIN-3-GLUCOSIDE-7-RHAMNOSIDE
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCITRIN
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCITRIN
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCITRIN
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HYPEROSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HYPEROSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
HYPEROSIDE
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RUTIN
ACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RUTIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RUTIN
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETAGETIN-7-O-BETA-D-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETAGETIN-7-O-BETA-D-GLUCOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
QUERCETAGETIN-7-O-BETA-D-GLUCOSIDE
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN
ACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN-7-O-BETA-D-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN-7-O-BETA-D-GLUCOSIDE
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
PATULETIN-7-O-BETA-D-GLUCOSIDE
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO:
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO:
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO:
STRONG ACTIVITY

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 3-(2-ACETYL)-GLUCOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 3-(2-ACETYL)-GLUCOSIDE
ACTIVE
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
RHAMNETIN,ISO: 3-(2-ACETYL)-GLUCOSIDE
INACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LIMOCITRIN
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LIMOCITRIN
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
LIMOCITRIN
ACTIVE

Unknown organism

Experiment #Pharmacology TypeWorktypesCompoundResults
1
LIPOXYGENASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICETIN-3-ARABINOSIDE
INACTIVE
2
CYCLOOXYGENASE STIMULATION
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICETIN-3-ARABINOSIDE
STRONG ACTIVITY
3
ANTIOXIDANT ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
MYRICETIN-3-ARABINOSIDE
ACTIVE
Show SPARQL Queries (1)